Beta-Glucan Market Research Report Information By Source (Yeast, Mushroom, Cereals, and Microalgae), By Application (Food & Beverages, Animal Feed, Personal Care, Pharmaceuticals, and Others), By Type ((1,3) Beta Glucan, (1,4) Beta Glucan, and (1,6) Beta Glucan), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL BETA-GLUCAN MARKET, BY SOURCE

6.1. Overview

6.2. Yeast

6.3. Mushroom

6.4. Cereals

6.5. Microalgae

7. GLOBAL BETA-GLUCAN MARKET, BY APPLICATION

7.1. Overview

7.2. Food & Beverages

7.3. Animal Feed

7.4. Personal Care

7.5. Pharmaceuticals

7.6. Others

8. GLOBAL BETA-GLUCAN MARKET, BY TYPE

8.1. Overview

8.2. (1,3) Beta Glucan

8.3. (1,4) Beta Glucan

8.4. (1,6) Beta Glucan

9. GLOBAL BETA-GLUCAN MARKET, BY REGION

9.1. Overview

9.2. North America

9.2.1. U.S.

9.2.2. Canada

9.3. Europe

9.3.1. Germany

9.3.2. France

9.3.3. U.K

9.3.4. Italy

9.3.5. Spain

9.3.6. Rest of Europe

9.4. Asia-Pacific

9.4.1. China

9.4.2. India

9.4.3. Japan

9.4.4. South Korea

9.4.5. Australia

9.4.6. Rest of Asia-Pacific

9.5. Rest of the World

9.5.1. Middle East

9.5.2. Africa

9.5.3. Latin America

10. COMPETITIVE LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Beta-Glucan Market,

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global Beta-Glucan Market,

10.7. Key developments and Growth Strategies

10.7.1. New Product Launch/Application Deployment

10.7.2. Merger & Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales & Operating Income, 2022

10.8.2. Major Players R&D Expenditure. 2022

11. COMPANY PROFILES

11.1. Kerry Group plc.

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Products Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Givaudan SA

11.2.1. Company Overview

11.2.2. Financial Overview

11.2.3. Products Offered

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Koninklijke DSM N.V.

11.3.1. Company Overview

11.3.2. Financial Overview

11.3.3. Products Offered

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Euglena Co. Ltd

11.4.1. Company Overview

11.4.2. Financial Overview

11.4.3. Products Offered

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Biotec Pharmacon ASA

11.5.1. Company Overview

11.5.2. Financial Overview

11.5.3. Products Offered

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. TATE & LYLE PLC.

11.6.1. Company Overview

11.6.2. Financial Overview

11.6.3. Products Offered

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Lesaffre Group

11.7.1. Company Overview

11.7.2. Financial Overview

11.7.3. Products Offered

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Kemin Industries, Inc.

11.8.1. Company Overview

11.8.2. Financial Overview

11.8.3. Products Offered

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. ABF Ingredients

11.9.1. Company Overview

11.9.2. Financial Overview

11.9.3. Products Offered

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Super Beta Glucan

11.10.1. Company Overview

11.10.2. Financial Overview

11.10.3. Products Offered

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

11.11. Garuda International, Inc.

11.11.1. Company Overview

11.11.2. Financial Overview

11.11.3. Products Offered

11.11.4. Key Developments

11.11.5. SWOT Analysis

11.11.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL BETA-GLUCAN MARKET, SYNOPSIS, 2020-2032

TABLE 2 GLOBAL BETA-GLUCAN MARKET, ESTIMATES & FORECAST, 2020-2032 (USD BILLION)

TABLE 3 GLOBAL BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)

TABLE 4 GLOBAL BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)

TABLE 5 GLOBAL BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)

TABLE 6 NORTH AMERICA BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)

TABLE 7 NORTH AMERICA BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)

TABLE 8 NORTH AMERICA BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)

TABLE 9 NORTH AMERICA BETA-GLUCAN MARKET, BY COUNTRY, 2020-2032 (USD BILLION)

TABLE 10 U.S. BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)

TABLE 11 U.S. BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)

TABLE 12 U.S. BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)

TABLE 13 CANADA BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)

TABLE 14 CANADA BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)

TABLE 15 CANADA BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)

TABLE 16 EUROPE BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)

TABLE 17 EUROPE BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)

TABLE 18 EUROPE BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)

TABLE 19 EUROPE BETA-GLUCAN MARKET, BY COUNTRY, 2020-2032 (USD BILLION)

TABLE 20 GERMANY BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)

TABLE 21 GERMANY BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)

TABLE 22 GERMANY BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)

TABLE 23 FRANCE BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)

TABLE 24 FRANCE BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)

TABLE 25 FRANCE BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)

TABLE 26 ITALY BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)

TABLE 27 ITALY BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)

TABLE 28 ITALY BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)

TABLE 29 SPAIN BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)

TABLE 30 SPAIN BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)

TABLE 31 SPAIN BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)

TABLE 32 U.K BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)

TABLE 33 U.K BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)

TABLE 34 U.K BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)

TABLE 35 REST OF EUROPE BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)

TABLE 36 REST OF EUROPE BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)

TABLE 37 REST OF EUROPE BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)

TABLE 38 ASIA PACIFIC BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)

TABLE 39 ASIA PACIFIC BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)

TABLE 40 ASIA PACIFIC BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)

TABLE 41 ASIA PACIFIC BETA-GLUCAN MARKET, BY COUNTRY, 2020-2032 (USD BILLION)

TABLE 42 JAPAN BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)

TABLE 43 JAPAN BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)

TABLE 44 JAPAN BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)

TABLE 45 CHINA BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)

TABLE 46 CHINA BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)

TABLE 47 CHINA BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)

TABLE 48 INDIA BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)

TABLE 49 INDIA BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)

TABLE 50 INDIA BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)

TABLE 51 AUSTRALIA BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)

TABLE 52 AUSTRALIA BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)

TABLE 53 AUSTRALIA BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)

TABLE 54 SOUTH KOREA BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)

TABLE 55 SOUTH KOREA BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)

TABLE 56 SOUTH KOREA BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)

TABLE 57 REST OF ASIA-PACIFIC BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)

TABLE 58 REST OF ASIA-PACIFIC BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)

TABLE 59 REST OF ASIA-PACIFIC BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)

TABLE 60 REST OF WORLD BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)

TABLE 61 REST OF WORLD BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)

TABLE 62 REST OF WORLD BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)

TABLE 63 REST OF WORLD BETA-GLUCAN MARKET, BY COUNTRY, 2020-2032 (USD BILLION)

TABLE 64 MIDDLE EAST BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)

TABLE 65 MIDDLE EAST BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)

TABLE 66 MIDDLE EAST BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)

TABLE 67 AFRICA BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)

TABLE 68 AFRICA BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)

TABLE 69 AFRICA BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)

TABLE 70 LATIN AMERICA BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)

TABLE 71 LATIN AMERICA BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)

TABLE 72 LATIN AMERICA BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION) 

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL BETA-GLUCAN MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL BETA-GLUCAN MARKET

FIGURE 4 GLOBAL BETA-GLUCAN MARKET, SHARE (%), BY SOURCE, 2022

FIGURE 5 GLOBAL BETA-GLUCAN MARKET, SHARE (%), BY APPLICATION, 2022

FIGURE 6 GLOBAL BETA-GLUCAN MARKET, SHARE (%), BY TYPE, 2022

FIGURE 7 GLOBAL BETA-GLUCAN MARKET, SHARE (%), BY REGION, 2022

FIGURE 8 NORTH AMERICA: BETA-GLUCAN MARKET, SHARE (%), BY REGION, 2022

FIGURE 9 EUROPE: BETA-GLUCAN MARKET, SHARE (%), BY REGION, 2022

FIGURE 10 ASIA-PACIFIC: BETA-GLUCAN MARKET, SHARE (%), BY REGION, 2022

FIGURE 11 REST OF THE WORLD: BETA-GLUCAN MARKET, SHARE (%), BY REGION, 2022

FIGURE 12 GLOBAL BETA-GLUCAN MARKET: COMPANY SHARE ANALYSIS, 2022 (%)

FIGURE 13 KERRY GROUP PLC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14 KERRY GROUP PLC.: SWOT ANALYSIS

FIGURE 15 GIVAUDAN SA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16 GIVAUDAN SA: SWOT ANALYSIS

FIGURE 17 KONINKLIJKE DSM N.V.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 KONINKLIJKE DSM N.V.: SWOT ANALYSIS

FIGURE 19 EUGLENA CO. LTD: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 EUGLENA CO. LTD: SWOT ANALYSIS

FIGURE 21 BIOTEC PHARMACON ASA.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 BIOTEC PHARMACON ASA.: SWOT ANALYSIS

FIGURE 23 TATE & LYLE PLC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 TATE & LYLE PLC.: SWOT ANALYSIS

FIGURE 25 LESAFFRE GROUP: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 LESAFFRE GROUP: SWOT ANALYSIS

FIGURE 27 KEMIN INDUSTRIES, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 KEMIN INDUSTRIES, INC.: SWOT ANALYSIS

FIGURE 29 ABF INGREDIENTS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 ABF INGREDIENTS: SWOT ANALYSIS

FIGURE 31 SUPER BETA GLUCAN: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 SUPER BETA GLUCAN: SWOT ANALYSIS

FIGURE 33 GARUDA INTERNATIONAL, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 34 GARUDA INTERNATIONAL, INC.: SWOT ANALYSIS